MGH/Brigham hospital in Boston is already treating their pancreatic cancer patients with the new breakthrough drug daraxonrasib, even before the FDA has approved it.
They are doing this under the FDA's Expanded Access Program (EAP), often referred to as “compassionate use”.
I imagine other large hospitals are doing the same.
If you know someone with pancreatic cancer, this drug is already available. No one has to wait anymore.
Quoted:
Mass General Brigham Cancer Institute is excited to offer patients daraxonrasib, a groundbreaking new treatment for pancreatic cancer. Only weeks after this practice-changing therapy moved beyond clinical trials, our team began administering it through a carefully coordinated process designed to ensure safe access for patients. Mary Linton Peters, MD, a medical oncologist at Mass General Brigham Cancer Institute, discusses the significance of bringing this promising treatment to patients as quickly as possible. The Boston Globe chronicles Lazar Mandinov's journey as he took daraxonrasib for the first time. Patients receive ‘historic’ pill for deadly pancreatic cancer - The Boston Globe (BostonGlobe.com)
#daraxonrasibHD #pancreaticcancerHD #mghbrighamHD #cancerHD #rasHD
